{
    "medicine_id": "70cfdfff50b1fdc599eb65e6c8a056d0d5645ec7",
    "platform_id": "DB00964",
    "metadata": {
        "name": "Apraclonidine 5 75 mg 1mL Solution",
        "composition": "5 75 mg 1mL Apraclonidine",
        "clinical_particulars": {
            "therapeutic_indications": "For prevention or reduction of intraoperative and postoperative increases in intraocular pressure IOP before and after ocular laser surgery when used prophylactically Also used as a short term adjunctive therapy in patients with open angle glaucoma who are on maximally tolerated medical therapy requiring additional IOP reduction",
            "contraindications": {
                "disease": "Accidental or intentional ingestion of oral apraclonidine has been reported to cause apnea arrhythmias asthenia bradycardia conduction defects diminished or absent reflexes dryness of the mouth hypotension hypothermia hypoventilation irritability lethargy miosis pallor respiratory depression sedation or coma seizure somnolence transient hypertension and vomiting",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Apraclonidine significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06148",
                        "description": "The therapeutic efficacy of Apraclonidine can be decreased when used in combination with Mianserin"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "Linezolid may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "Furazolidone may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "Tranylcypromine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "Minaprine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "Selegiline may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "Procarbazine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "Moclobemide may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "Isocarboxazid may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "Pargyline may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "Clorgiline may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "Iproniazid may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "Nialamide may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Methylene blue may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "Hydracarbazine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Pirlindole may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Toloxatone may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "Benmoxin may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "Mebanazine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "Octamoxin may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "Pheniprazine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "Phenoxypropazine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "Pivhydrazine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "Safrazine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "Caroxazone may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "Harmaline may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "Brofaromine may increase the alpha adrenergic activities of Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The serum concentration of Apraclonidine can be increased when it is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Apraclonidine can be decreased when combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Apraclonidine can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Apraclonidine can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "Apraclonidine may increase the sympathomimetic activities of Formoterol"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Apraclonidine can be increased when it is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The serum concentration of Apraclonidine can be increased when it is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of hypotension can be increased when Sildenafil is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "The risk or severity of hypotension can be increased when Milrinone is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The risk or severity of hypotension can be increased when Pentoxifylline is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "The risk or severity of hypotension can be increased when Tadalafil is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of hypotension can be increased when Vardenafil is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of hypotension can be increased when Dipyridamole is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of hypotension can be increased when Ibudilast is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB06237",
                        "description": "The risk or severity of hypotension can be increased when Avanafil is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The risk or severity of hypotension can be increased when Udenafil is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of hypotension can be increased when Doxofylline is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB11792",
                        "description": "The risk or severity of hypotension can be increased when Mirodenafil is combined with Apraclonidine"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The risk or severity of hypotension can be increased when Fostamatinib is combined with Apraclonidine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}